Method for inhibiting hypoxia injury of myocardial AC16 cells
By acquiring image data of AC16 myocardial cells, combining spatial distribution and deformation fitting values to classify the degree of damage, and adjusting the injection location and concentration of transforming growth factor, the problem of inaccurate overall assessment in the method of inhibiting hypoxia damage in AC16 myocardial cells was solved, and a more precise damage inhibition effect was achieved.
Patent Information
- Application Number
- CN202511342871.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-09-19
- Publication Date
- 2026-02-10
AI Technical Summary
In the existing technology, the method for inhibiting hypoxia injury in myocardial AC16 cells fails to effectively consider the differences in cell damage under different environments, resulting in poor overall evaluation results and reduced experimental accuracy.
By acquiring image data of AC16 myocardial cells in culture dishes, spatial distribution features and deformation fitting values were extracted to classify the degree of damage. Based on the degree of damage category, the injection location and concentration of transforming growth factor were adjusted. Image analysis software was used to track the factor trajectory and evaluate the damage inhibition effect.
This study achieved precise inhibition of hypoxia-induced damage in AC16 myocardial cells, improving the effectiveness and accuracy of the experiment and ensuring the adaptive application of transforming growth factor in regions with different degrees of damage.
Smart Images

Figure CN121499442A_ABST
Abstract
Description
TECHNICAL FIELD
[0001] The present application relates to the field of image auxiliary analysis, and in particular to a method for inhibiting hypoxic injury of myocardial AC16 cells. BACKGROUND
[0002] Myocardial cells are extremely sensitive to oxygen supply, and hypoxic injury is an important pathophysiological process of many cardiovascular diseases such as myocardial infarction, ischemic heart disease, etc. Under hypoxic conditions, the energy metabolism, ion balance, cell structure and function of myocardial cells will be affected, and severe cases can lead to cell apoptosis and necrosis, and further affect the normal function of the heart. Taking myocardial infarction as an example, coronary artery obstruction leads to local hypoxia of myocardium, triggering a series of intracellular pathological changes, ultimately causing myocardial cell death and impaired cardiac function. Therefore, studying the method for inhibiting hypoxic injury of myocardial cells has important theoretical and clinical significance for preventing and treating cardiovascular diseases and protecting cardiac function.
[0003] Myocardial AC16 cells are a commonly used human myocardial cell line, which has some typical characteristics of myocardial cells, such as contractility and expression of myocardial specific proteins, and is often used for basic research related to myocardial cells. It is an important cell model for studying the mechanism of myocardial hypoxic injury and exploring inhibition methods.
[0004] Chinese patent application publication No. CN116555173A discloses a method for repairing oxidative damage of human myocardial cells in vitro. Human myocardial cells AC16 subjected to oxidative damage are cultured using a culture medium containing Yupingfeng Powder. By culturing human myocardial cells AC16 subjected to oxidative damage in vitro using a culture medium containing Yupingfeng Powder, it is found that after culture, the mRNA expression of Nrf2 and HO-1 in the oxidative damage marker of human myocardial cells AC16 is significantly increased, the mRNA expression of Keap1 is significantly decreased; the protein expression of HO-1 and NEs-Nrf2 is significantly increased, the protein expression of Keap1 is significantly decreased, and the protein expression of Nrf2 shows no obvious change; it is indicated that Yupingfeng Powder has obvious protective and repairing effects on oxidative damage of human myocardial cells AC16, and its mechanism is to regulate the Keap1 / Nrf2 / HO-1 pathway, inhibit the expression of Keap1, promote the nuclear translocation of Nrf2, and affect the protein expression of downstream HO-1, etc.
[0005] However, the prior art still has the following problems,
[0006] In the experiment of inhibiting hypoxic injury of myocardial AC16 cells, the improvement of the injected relief material on the whole myocardial AC16 cells in the culture dish is focused on, and the different environments of the myocardial AC16 cells are not considered, the damage degree of the myocardial AC16 cells in different environments is different, and the improvement degree of the uniform relief material injected into the myocardial AC16 cells in different environments is also different. Therefore, the evaluation of the inhibition degree of the relief material on the hypoxic injury of all myocardial AC16 cells in the culture dish according to the overall improvement is not good, and the evaluation is one-sided, which reduces the accuracy of the experiment. SUMMARY
[0007] Therefore, the present application provides a method for inhibiting hypoxic injury of myocardial AC16 cells to overcome the problem that the evaluation of the inhibition degree of the relief material on the hypoxic injury of all myocardial AC16 cells in the culture dish according to the overall improvement is not good, and the evaluation is one-sided, which reduces the accuracy of the experiment in the prior art.
[0008] To achieve the above-mentioned purpose, the present application provides a method for inhibiting hypoxic injury of myocardial AC16 cells, which comprises:
[0009] Obtaining image data of a plurality of myocardial AC16 cells in a culture dish to extract spatial distribution characteristics of the myocardial AC16 cells in the culture dish region, the spatial distribution characteristics including position depth and cell spacing;
[0010] According to the spatial distribution characteristics combined with the corresponding deformation fitting value, a hypoxic injury representation value of the myocardial AC16 cells is determined to divide the damage degree category of the myocardial AC16 cells;
[0011] Based on the damage degree category, the myocardial AC16 cells in the culture dish are adjusted and inhibited, including,
[0012] The transforming growth factor is stained and marked, the moving track of the transforming growth factor is obtained, the low-concentration area in the culture dish is determined, the low-concentration area image is collected, the contour feature of the myocardial AC16 cells in the low-concentration area is analyzed based on the continuous image frames to evaluate the damage inhibition degree representation parameter, whether to continue injecting the transforming growth factor is judged based on the damage inhibition degree representation parameter, and the injection of the transforming growth factor is increased in the corresponding area according to the damage inhibition degree representation parameter;
[0013] Or, the transforming growth factor is injected at the center position of the culture dish, and the dense distribution area in the culture dish is identified for injection of the transforming growth factor;
[0014] The contour feature includes deformation recovery amount and color difference uniformity.
[0015] Further, the process of determining the hypoxia injury characterization value of the myocardial AC16 cells according to the spatial distribution feature combined with the deformation fitting value includes
[0016] Taking the sum of the ratio of the position depth to the position depth threshold value and the ratio of the cell spacing threshold value to the cell spacing as the first hypoxia injury feature;
[0017] Taking the ratio of the deformation fitting value to the deformation fitting threshold value as the second hypoxia injury feature;
[0018] The first hypoxia injury feature and the second hypoxia injury feature are weighted and summed as the hypoxia injury characterization value.
[0019] Further, the damage degree category of the myocardial AC16 cells is divided, including,
[0020] If the hypoxia injury characterization value is greater than or equal to the hypoxia injury characterization threshold value, the damage degree category of the myocardial AC16 cells is divided into a high damage degree category;
[0021] If the hypoxia injury characterization value is less than the hypoxia injury characterization threshold value, the damage degree category of the myocardial AC16 cells is divided into a low damage degree category.
[0022] Further, based on the damage degree category, the myocardial AC16 cells in the culture dish are adjusted and inhibited, including,
[0023] If the myocardial AC16 cells are in the high damage degree category, the transforming growth factor is stained and labeled, the moving track of the transforming growth factor is obtained, the low concentration area in the culture dish is determined, the low concentration area image is collected, the contour feature of the myocardial AC16 cells in the low concentration area is analyzed based on the continuous image frames, the damage inhibition degree characterization parameter is evaluated, whether to continue injecting the transforming growth factor is judged based on the damage inhibition degree characterization parameter, and the injection of the transforming growth factor is increased in the corresponding area according to the damage inhibition degree characterization parameter;
[0024] If the myocardial AC16 cells are in the low damage degree category, the transforming growth factor is injected at the center position of the culture dish, and the dense distribution area in the culture dish is identified for injection of the transforming growth factor.
[0025] Further, the process of obtaining the moving track of the transforming growth factor includes,
[0026] Continuous imaging of the culture dish is obtained at a predetermined time interval, and the fluorescence image of the transforming growth factor is recorded;
[0027] According to the image analysis software, the fluorescence signal of the transforming growth factor in the fluorescence image is identified and located;
[0028] According to the position coordinates of the fluorescence signals corresponding to the adjacent time interval points, a moving track of the transforming growth factor is established.
[0029] Further, the process of determining the low-concentration region in the culture dish comprises,
[0030] If the number of the moving track convergences of any region is greater than or equal to the convergence number threshold, the region is determined as the low-concentration region.
[0031] Further, the process of evaluating the damage inhibition degree representation parameter comprises
[0032] The ratio of the deformation recovery amount to the deformation recovery amount threshold is taken as a first damage inhibition feature;
[0033] The ratio of the color difference uniformity to the color difference uniformity threshold is taken as a second damage inhibition feature;
[0034] The sum of the first damage inhibition feature and the second damage inhibition feature is taken as the damage inhibition degree representation value.
[0035] Further, the process of determining whether to continue injecting the transforming growth factor based on the damage inhibition degree representation parameter comprises,
[0036] If the damage inhibition degree representation parameter is less than the damage inhibition representation parameter threshold, it is determined to continue injecting the transforming growth factor.
[0037] Further, the process of increasing the injection of the transforming growth factor in the corresponding region according to the damage inhibition degree representation parameter comprises,
[0038] The injection increase amount of the transforming growth factor is negatively correlated with the damage inhibition degree representation parameter.
[0039] Further, the process of identifying the dense distribution region in the culture dish comprises,
[0040] If the number of myocardial AC16 cells in any region is greater than or equal to the number threshold, the region is identified as the dense distribution region.
[0041] Compared with the prior art, the application extracts the spatial distribution characteristics of myocardial AC16 cells in the culture dish area by acquiring image data of a plurality of myocardial AC16 cells in the culture dish, determines the hypoxic injury representation value of the myocardial AC16 cells according to the spatial distribution characteristics combined with the corresponding deformation fitting value, classifies the injury degree category of the myocardial AC16 cells, and adaptively adjusts and inhibits the myocardial AC16 cells in the culture dish based on the injury degree category. The application converts growth factors into the inhibition effect on the hypoxic injury myocardial AC16 cells through image auxiliary analysis, and ensures the effectiveness of the experiment.
[0042] Especially, the application determines the hypoxic injury representation value by combining the spatial distribution characteristics with the corresponding deformation fitting value of the myocardial AC16 cells. In actual situations, the position depth of the myocardial AC16 cells in the culture dish can reflect the microenvironment difference thereof, and meanwhile, the myocardial AC16 cells can be more easily affected by the diffusion limitation of nutrients and the accumulation of metabolic waste, and the injury risk thereof in the hypoxic environment is aggravated. The distance between the myocardial AC16 cells affects the signal transmission, material exchange and nutrition competition therebetween. The myocardial AC16 cells will change in shape in the hypoxic environment, and the deformation fitting value is used to quantitatively represent the shape change degree of the myocardial AC16 cells in the hypoxic environment, reflect the change of the internal structure and function of the cells, and further affect the tolerance of the cells to the hypoxic injury. Therefore, the application combines the spatial distribution characteristics with the corresponding deformation fitting value to comprehensively evaluate the hypoxic injury of the cells from two aspects of the spatial position relationship of the cells and the shape change of the cells, determines the hypoxic injury representation value to represent the injury degree of the myocardial AC16 cells in the hypoxic environment, provides data support for classifying the injury degree category of the myocardial AC16 cells, further adaptively adjusts and inhibits the myocardial AC16 cells in the culture dish, and converts growth factors into the inhibition effect on the hypoxic injury myocardial AC16 cells through image auxiliary analysis, thereby ensuring the effectiveness of the experiment.
[0043] Especially, when the myocardial AC16 cells in the petri dish of the high damage degree category are adjusted and inhibited, the contour features of the myocardial AC16 cells in the low concentration area are analyzed to reflect the damage inhibition recovery of the myocardial AC16 cells in the low oxygen environment under the action of the transforming growth factor, wherein the morphological repair of the myocardial AC16 cells under the action of the transforming growth factor is reflected by the deformation recovery amount, and the protection and repair degree of the transforming growth factor on the myocardial AC16 cells are further reflected; the material distribution uniformity in the cells is reflected by the color difference uniformity, so that the damage inhibition degree characteristic parameters are evaluated by analyzing the above indexes, the inhibition effect of the transforming growth factor on the myocardial AC16 cells is grasped in time and accurately, data support is provided for subsequent determination of whether to continue to inject the transforming growth factor, and the inhibition effect of the transforming growth factor on the myocardial AC16 cells damaged by the low oxygen is analyzed by the image to ensure the effectiveness of the experiment. BRIEF DESCRIPTION OF DRAWINGS
[0044] Figure 1 The step schematic diagram of the myocardial AC16 cell low oxygen damage inhibition method of the embodiment of the application is shown in the figure.
[0045] Figure 2 The logic determination diagram for dividing the damage degree category of the myocardial AC16 cells of the embodiment of the application is shown in the figure.
[0046] Figure 3 The logic determination diagram for determining the low concentration area in the petri dish of the embodiment of the application is shown in the figure.
[0047] Figure 4 The logic determination diagram for determining whether to continue to inject the transforming growth factor of the embodiment of the application is shown in the figure. DETAILED DESCRIPTION
[0048] In order to make the purpose and advantages of the application more clear and obvious, the application is further described below in combination with the embodiments; it should be understood that the specific embodiments described herein are only used to explain the application, and are not used to limit the application.
[0049] The preferred embodiments of the application are described below with reference to the drawings. Those skilled in the art should understand that these embodiments are only used to explain the technical principles of the application, and are not used to limit the protection scope of the application.
[0050] It should be noted that in the description of the application, the terms indicating the direction or position relationship such as "inner" are based on the direction or position relationship shown in the drawings, which is only for the convenience of description, and does not indicate or imply that the device or element must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation on the application.
[0051] Please refer to Figure 1As shown, it is the step schematic diagram of the method for inhibiting hypoxic injury of myocardial AC16 cells according to the embodiment of the application, and the method for inhibiting hypoxic injury of myocardial AC16 cells according to the embodiment of the application comprises the following steps:
[0052] In step S1, image data of a plurality of myocardial AC16 cells in a culture dish is acquired to extract spatial distribution characteristics of the myocardial AC16 cells in the culture dish region, and the spatial distribution characteristics include position depth and cell spacing;
[0053] In step S2, a hypoxic injury characterization value of the myocardial AC16 cells is determined according to the spatial distribution characteristics and corresponding deformation fitting values to classify the injury degree category of the myocardial AC16 cells;
[0054] In step S3, the myocardial AC16 cells in the culture dish are adjusted and inhibited based on the injury degree category, including,
[0055] The transforming growth factor is stained and marked, the moving track of the transforming growth factor is acquired, the low-concentration region in the culture dish is determined, a low-concentration region image is acquired, the contour feature of the myocardial AC16 cells in the low-concentration region is analyzed based on continuous image frames to evaluate an injury inhibition degree characterization parameter, it is judged whether to continue injecting the transforming growth factor based on the injury inhibition degree characterization parameter, and the injection of the transforming growth factor is increased in the corresponding region according to the injury inhibition degree characterization parameter;
[0056] Alternatively, the transforming growth factor is injected at the center position of the culture dish, and the dense distribution region in the culture dish is identified for injection of the transforming growth factor;
[0057] The contour feature includes deformation recovery amount and color difference uniformity.
[0058] Specifically, the manner of acquiring image data of a plurality of myocardial AC16 cells in a culture dish is not specifically limited, and a three-dimensional image of the myocardial AC16 cells can be acquired by layer-by-layer scanning of the myocardial AC16 cells in the culture dish through a laser scanning confocal microscope to realize accurate measurement of the image data of the myocardial AC16 cells, and then the position depth and cell spacing of the myocardial AC16 cells are extracted. Of course, other methods can also be used, which will not be described here.
[0059] Specifically, the transforming growth factor refers to GDF15 protein, and any one of the existing techniques can be used for staining, such as immunofluorescence staining, which will not be described here.
[0060] Specifically, the process of determining the hypoxic injury characterization value of the myocardial AC16 cells according to the spatial distribution characteristics and corresponding deformation fitting values comprises
[0061] The sum of the ratio of location depth to location depth threshold and the ratio of intercellular distance threshold to intercellular distance is used as the first feature of hypoxia injury.
[0062] The ratio of the deformation fitting value to the deformation fitting threshold is used as the second hypoxia injury feature.
[0063] The weighted sum of the first hypoxia damage feature and the second hypoxia damage feature is used as the hypoxia damage characterization value.
[0064] In practice, the spatial distribution characteristics of several myocardial AC16 cells in a culture dish can reflect the different microenvironments in which different myocardial AC16 cells are located. Different microenvironments have different degrees of impact on the damage of myocardial AC16 cells under hypoxia. Spatial distribution characteristics can more directly reflect the damage impact on myocardial AC16 cells. Therefore, in practice, spatial distribution characteristics, namely the position and depth of myocardial AC16 cells in the culture dish and the intercellular distance, are given priority. Thus, the first hypoxia damage characteristic calculated based on spatial distribution characteristics is given a slightly higher weight. Therefore, in the weighted summation, the weight of the first hypoxia damage characteristic is set to 0.6, and the weight of the second hypoxia damage characteristic is set to 0.4.
[0065] The purpose of setting the location depth threshold, intercellular distance threshold, and deformation fitting threshold is to characterize the extent to which the microenvironment in which myocardial AC16 cells are located has a significant impact on the damage to myocardial AC16 cells. Therefore, by acquiring historical data from several experiments conducted under the same experimental conditions to inhibit hypoxia injury in myocardial AC16 cells, historical data on location depth, intercellular distance, and deformation fitting values are retrieved, and the mean values of location depth, intercellular distance, and deformation fitting are calculated. Based on the purpose of setting the location depth threshold, intercellular distance threshold, and deformation fitting threshold, the location depth threshold is set as the product of the mean location depth and the depth deviation coefficient, the intercellular distance threshold is set as the product of the mean intercellular distance and the distance deviation coefficient, and the deformation fitting threshold is set as the product of the mean deformation fitting and the fitting offset coefficient. The depth deviation coefficient is selected within the interval [1.05, 1.08], the product of the distance deviation coefficients is selected within the interval [0.9, 0.95], and the fitting offset coefficient is selected within the interval [1.05, 1.1].
[0066] It is understandable that the shape of AC16 myocardial cells will change under the influence of low temperature. The first cell image of AC16 myocardial cells with shape changes is obtained and matched with the second cell image of AC16 myocardial cells in normal condition that is stored in advance to determine the deformation fitting value.
[0067] In some possible implementations, a deep learning fitting method is used to extract feature vectors of the first cell image and the second cell image using a pre-trained convolutional neural network model, such as VGG or ResNet. The similarity between the two cell images is measured by calculating the distance between the feature vectors, such as cosine distance or Euclidean distance, and the similarity is determined as the deformation fitting value.
[0068] In some other possible embodiments, the similarity between the two cells is determined by a method based on image segmentation and template matching, and the similarity is determined as the deformation fitting value. The process includes: segmenting the two cell images and separating them from the background; selecting the separated second cell image as a template; using a template matching algorithm, such as grayscale-based template matching or feature-based template matching, to perform template matching in the first cell image; and determining the similarity between the two cell images by calculating the similarity between the corresponding regions of the second image cell (which serves as the template) and the first image cell. Of course, other methods can also be used to determine the deformation fitting value of the myocardial AC16 cells, which will not be elaborated here.
[0069] Similarly, AC16 myocardial cells damaged by hypoxia gradually recover their shape under the action of transforming growth factor. Therefore, a third cell image of the corresponding AC16 myocardial cells after injection of transforming growth factor is obtained. The second similarity between the third cell image and the second cell image is determined in the above manner, and the first similarity between the first cell image and the second cell image is called. The difference between the first similarity and the second similarity is used as the deformation recovery amount.
[0070] Specifically, this invention determines the hypoxia injury characterization value by combining spatial distribution characteristics with the deformation fitting value corresponding to myocardial AC16 cells. In practice, the location and depth of myocardial AC16 cells in the culture dish can reflect the differences in their microenvironment. For example, myocardial AC16 cells located at a deeper depth are farther from the surface of the culture medium, and oxygen needs to diffuse through more cell layers and culture medium to reach them, so the oxygen supply is relatively more insufficient. At the same time, myocardial AC16 cells may be more susceptible to the effects of nutrient diffusion restriction and metabolic waste accumulation, which aggravates their damage risk in a hypoxic environment.
[0071] The distance between AC16 myocardial cells affects their signal transduction, material exchange, and nutrient competition. For example, smaller intercellular distances result in narrower diffusion paths for nutrients and oxygen, leading to intense competition. A large number of cells may simultaneously absorb limited nutrients and oxygen, resulting in relatively less for each cell. This can exacerbate nutrient deficiency and hypoxia. Furthermore, in a hypoxic environment, tight signaling can lead to the rapid propagation of adverse signals, such as apoptosis signals. If some cells initiate apoptosis due to severe hypoxia, it may rapidly affect surrounding cells through intercellular signal transduction, triggering a chain reaction. At the same time, cellular metabolites tend to accumulate in intercellular spaces and are difficult to diffuse rapidly into the surrounding environment. High concentrations of metabolites can alter the pH and ion concentration of the extracellular microenvironment, affecting normal cellular physiological functions, such as interfering with the activity of ion channels on the cell membrane, thereby affecting cell excitability and contractility. Long-term accumulation may also cause toxic damage to cells, triggering inflammatory responses or apoptosis.
[0072] Myocardial AC16 cells undergo morphological changes under hypoxic conditions, such as cell swelling, shrinkage, or deformation. The degree of morphological changes of myocardial AC16 cells under hypoxic conditions can be quantitatively characterized by deformation fitting values, reflecting changes in the internal structure and function of the cells. For example, cells located at deeper depths are subjected to greater pressure from the cells above, affecting the cell morphology, skeletal structure, etc., and thus affecting the cell's tolerance to hypoxic damage.
[0073] Therefore, this invention combines spatial distribution characteristics with corresponding deformation fitting values to comprehensively assess the hypoxic damage of cells from two aspects: the spatial positional relationship of cells and their own morphological changes. It determines the hypoxic damage characterization value to characterize the degree of damage of each myocardial AC16 cell in a hypoxic environment, providing data support for classifying the degree of damage of myocardial AC16 cells. Furthermore, it adaptively adjusts and inhibits myocardial AC16 cells in culture dishes. This invention uses image-assisted analysis to analyze the inhibitory effect of transforming growth factor on hypoxic-damaged myocardial AC16 cells, ensuring the validity of the experiment.
[0074] Specifically, please refer to Figure 2 As shown, this is a logic diagram for classifying the degree of damage to AC16 myocardial cells according to an embodiment of the present invention. The classification of the degree of damage to AC16 myocardial cells includes:
[0075] If the hypoxia injury characterization value is greater than or equal to the hypoxia injury characterization threshold, the damage level of the myocardial AC16 cells is classified as a high-damage category.
[0076] If the hypoxia injury characterization value is less than the hypoxia injury characterization threshold, the damage level of the myocardial AC16 cells is classified as low damage level.
[0077] The threshold for characterizing hypoxia injury was selected within the range [1.68, 1.75].
[0078] Specifically, based on the aforementioned damage severity category, the cardiac AC16 cells in the culture dish are modulated and inhibited, including,
[0079] If the myocardial AC16 cells are classified as high-damage cells, transforming growth factor (TGF) is stained and labeled to obtain the TGF's movement trajectory. Low-concentration regions in the culture dish are identified, and images of these low-concentration regions are acquired. The contour features of myocardial AC16 cells within these low-concentration regions are analyzed based on consecutive image frames to assess damage inhibition degree characterization parameters. Based on these damage inhibition degree characterization parameters, it is determined whether to continue injecting TGF. The injection of TGF is increased in the corresponding regions according to the damage inhibition degree characterization parameters.
[0080] If the AC16 myocardial cells are classified as low-damage, transforming growth factor is injected into the center of the culture dish, and the injection of transforming growth factor is performed in densely distributed areas within the culture dish.
[0081] Specifically, the process of obtaining the movement trajectory of the transforming growth factor includes,
[0082] Continuous imaging of the culture dish is acquired at predetermined time intervals, and the fluorescence images of the transforming growth factor are recorded;
[0083] Based on image analysis software, the fluorescence signal of the transforming growth factor in the fluorescence image is identified and located;
[0084] The movement trajectory of the transforming growth factor is established based on the position coordinates of the fluorescence signal corresponding to adjacent time intervals.
[0085] In this embodiment, the movement of transforming growth factor (TGF) is tracked using a laser scanning confocal microscope capable of providing high-resolution three-dimensional images, thereby determining the TGF's trajectory. Cells in the culture dish are continuously imaged at predetermined time intervals. Then, image analysis software, such as ImageJ, is used to identify and locate the fluorescence signal of TGF. Based on the trajectory tracking algorithm used in the image analysis software, commonly including feature point matching, particle filtering, and Kalman filtering, a movement trajectory is established based on the positional information of the fluorescence signal at adjacent time intervals, accurately tracking the movement of TGF. The acquired movement trajectory is presented visually, for example, using lines or dots to represent the trajectory, providing clear support for subsequent identification of low-concentration areas. Of course, those skilled in the art can also use other methods to obtain the movement trajectory of TGF, which will not be elaborated here.
[0086] Regarding the setting of the predetermined time interval, considering that AC16 myocardial cells in the culture dish have a rapid uptake or initial signal transduction response to transforming growth factor, resulting in a relatively fast movement speed of transforming growth factor, in this embodiment, the predetermined time interval is selected within the range of [1 min, 5 min].
[0087] Specifically, please refer to Figure 3 As shown, this is a logic decision diagram for determining a low-concentration region in a petri dish according to an embodiment of the present invention. The process of determining the low-concentration region in the petri dish includes:
[0088] If the number of aggregated movement trajectories in any region is greater than or equal to the aggregation number threshold, then the region is identified as a low-concentration region.
[0089] In this embodiment, the purpose of setting a pooling quantity threshold is to characterize the situation where the concentration of transforming growth factor (TGF) in the final residence area of TGF is low, reflecting the movement of TGF in the culture dish, thus resulting in poor inhibitory effect on hypoxia damage of AC16 myocardial cells in that area. Therefore, based on the fact that TGF diffuses from high concentration areas to low concentration areas, the latest position points of several TGF movement trajectories are determined by analyzing the movement trajectory of TGF. The distribution area of the fluorescence signal of TGF corresponding to the latest position point is analyzed to determine the pooling quantity of movement trajectories in each area. By obtaining historical data of several hypoxia damage inhibition experiments of AC16 myocardial cells under the same experimental conditions, the historical pooling quantity data is called to solve for the mean pooling quantity. Based on the purpose of setting the pooling quantity threshold, the pooling quantity threshold is set as the product of the mean pooling quantity and the quantity deviation coefficient, wherein the quantity deviation coefficient is selected in the interval [1.15, 1.2].
[0090] Specifically, there are no specific restrictions on the method of dividing the area. For the convenience of experimental observation, the petri dish can be divided into several equal areas, which will not be elaborated further.
[0091] Specifically, the process of assessing the characterization parameters of damage inhibition includes:
[0092] The ratio of deformation recovery to deformation recovery threshold is used as the first damage suppression feature;
[0093] The ratio of color difference uniformity to color difference uniformity threshold is used as the second damage suppression feature;
[0094] The sum of the first damage suppression feature and the second damage suppression feature is used as the damage suppression degree characterization value.
[0095] In this embodiment, the purpose of setting the deformation recovery threshold and the color difference uniformity threshold is to characterize the situation where transforming growth factor has a good inhibitory effect on hypoxia injury of myocardial AC16 cells. The deformation recovery threshold and the color difference uniformity threshold are determined based on the mean deformation recovery value and the mean color difference uniformity value, respectively. Historical data of several experiments on the inhibition of hypoxia injury of myocardial AC16 cells under the same experimental conditions are obtained. The historical data of deformation recovery value and the historical data of color difference uniformity are called to determine the mean deformation recovery value and the mean color difference uniformity value. Based on the purpose of setting the above two thresholds, the deformation recovery threshold is determined as the product of the mean deformation recovery value and the recovery deviation coefficient, and the color uniformity threshold is determined as the product of the mean color uniformity value and the uniformity deviation coefficient. The recovery deviation coefficient is selected in the interval [1.05, 1.1], and the uniformity deviation coefficient is selected in the interval [1.1, 1.15].
[0096] Under normal circumstances, the color of AC16 myocardial cells is relatively uniform, that is, the color gradient from the center to the edge of the AC16 myocardial cell is small, there is no large color difference, and the color difference uniformity is high. In this embodiment, the color of AC16 myocardial cells from the center to the edge is quantitatively analyzed by the image analysis software ImageJ and its measurement tools to determine the color difference uniformity. This will not be elaborated further.
[0097] Specifically, when this invention modulates the inhibition of myocardial AC16 cells in culture dishes of high-injury levels, it analyzes the contour features of myocardial AC16 cells in low-concentration areas to reflect the damage inhibition and recovery of myocardial AC16 cells under hypoxic conditions by transforming growth factor. The deformation recovery amount reflects the morphological repair of myocardial AC16 cells under the action of transforming growth factor, further reflecting the degree of protection and repair of myocardial AC16 cells by transforming growth factor.
[0098] Color uniformity reflects the evenness of the distribution of substances within cells. Under normal conditions, the metabolic activity of AC16 myocardial cells is relatively balanced, and the distribution of substances within the cells is relatively uniform. The color gradient from the center to the edge of the cell is small, and the color uniformity is high. However, under hypoxic injury, the metabolism of AC16 myocardial cells is affected. The central part of the cell, being relatively far from the source of nutrients and oxygen, may experience hypoxia first, leading to metabolic disorders. The synthesis or decomposition of some substances is affected, such as changes in the distribution of pigments within the cell and swelling of organelles. This may cause the color in the center of the cell to become darker or lighter, while the edge of the cell may still maintain relatively normal metabolism with relatively small color changes. This results in an increase in color difference from the center to the edge and a decrease in color uniformity.
[0099] Therefore, by analyzing the above indicators, this invention evaluates the damage inhibition degree characterization parameters, and timely and accurately grasps the inhibitory effect of transforming growth factor on myocardial AC16 cell damage, providing data support for subsequent determination of whether to continue injecting transforming growth factor. This invention uses image-assisted analysis to determine the inhibitory effect of transforming growth factor on hypoxic myocardial AC16 cells, ensuring the validity of the experiment.
[0100] Specifically, please refer to Figure 4 As shown, this is a logic diagram for determining whether to continue injecting transforming growth factor according to an embodiment of the present invention. The determination of whether to continue injecting the transforming growth factor based on the damage inhibition degree characterization parameter includes:
[0101] If the damage inhibition degree characterization parameter is less than the damage inhibition characterization parameter threshold, then it is determined that the transformation growth factor should continue to be injected;
[0102] If the damage inhibition degree characterization parameter is greater than or equal to the damage inhibition characterization parameter threshold, it is determined that there is no need to continue injecting the transforming growth factor.
[0103] The threshold for the damage suppression characterization parameter is selected within the range [0.87, 0.95].
[0104] Specifically, based on the damage inhibition degree characterization parameters, the injection of the transforming growth factor into the corresponding region is increased, including:
[0105] The increase in the amount of transforming growth factor injected is negatively correlated with the damage inhibition degree characterization parameter.
[0106] In this embodiment, optionally,
[0107] The damage inhibition degree characterization parameter is compared with the first damage inhibition degree characterization parameter comparison threshold and the second damage inhibition degree characterization parameter comparison threshold.
[0108] When the damage inhibition degree characterization parameter is greater than the comparison threshold of the second damage inhibition degree characterization parameter, the injection increase is determined to be the first increase, which is set to be 0.2 times the baseline injection amount.
[0109] When the damage inhibition degree characterization parameter is greater than or equal to the first damage inhibition degree characterization parameter comparison threshold and less than or equal to the second damage inhibition degree characterization parameter comparison threshold, the injection increase is determined to be the second increase, and the second increase is set to be 0.3 times the baseline injection amount.
[0110] When the damage inhibition degree characterization parameter is less than the comparison threshold of the first damage inhibition degree characterization parameter, the injection increase is determined to be the third increase, which is set to be 0.4 times the baseline injection amount.
[0111] Among them, the comparison threshold for the first damage inhibition degree characterization parameter is 1.1 times the threshold for the damage inhibition degree characterization parameter, and the comparison threshold for the second damage inhibition degree characterization parameter is 1.3 times the threshold for the damage inhibition degree characterization parameter.
[0112] Specifically, the process of identifying densely distributed regions in the culture dish includes,
[0113] If the number of AC16 myocardial cells in any region is greater than or equal to the number threshold, then the region is identified as the densely distributed region.
[0114] Understandably, cardiac AC16 cells undergo autonomous proliferation in culture dishes. Under conditions where hypoxia has little impact on cardiac AC16 cells and the damage is relatively mild, they can still maintain basic metabolism and physiological functions. Although hypoxia does exert some stress on cardiac AC16 cells, their self-regulation and adaptive capabilities activate signaling pathways to promote cell survival and proliferation. For example, the expression of some growth factors and cell cycle regulatory proteins may increase, prompting cells to enter the cell cycle and divide. Therefore, in this embodiment, the purpose of setting a cell number threshold is to characterize the situation where there are a large number of AC16 myocardial cells in a certain area of the culture dish, and the injected transforming growth factor does not fully inhibit the large number of AC16 myocardial cells. By obtaining historical data of several experiments on inhibiting hypoxia injury of AC16 myocardial cells under the same experimental conditions, the historical data of the number of AC16 myocardial cells in each area of the culture dish are called to solve for the mean cell number. Based on the purpose of setting a cell number threshold, the cell number threshold is set as the product of the mean cell number and the number deviation coefficient, wherein the number deviation coefficient is selected in the interval [1.6,2].
[0115] If the method for inhibiting hypoxia injury of AC16 myocardial cells of the present invention is implemented as a software functional unit and sold or used as an independent product, it can be stored in a computer-readable storage medium. Based on this understanding, the technical solution of the present invention, or the part that contributes to the prior art, or all or part of the technical solution, can be embodied in the form of a software product. The computer software product is stored in a storage medium and includes several instructions to cause a computer device (which may be a personal computer, a server, or a network device, etc.) to execute all or part of the steps of the method described in the various embodiments of the present invention. The aforementioned storage medium includes various media that can store program code, such as USB flash drives, mobile hard drives, read-only memory (ROM), random access memory (RAM), magnetic disks, or optical disks.
[0116] The technical solution of the present invention has been described above with reference to the preferred embodiments shown in the accompanying drawings. However, it will be readily understood by those skilled in the art that the scope of protection of the present invention is obviously not limited to these specific embodiments. Without departing from the principles of the present invention, those skilled in the art can make equivalent changes or substitutions to the relevant technical features, and the technical solutions after these changes or substitutions will all fall within the scope of protection of the present invention.
Claims
1. A method for inhibiting hypoxia injury in myocardial AC16 cells, characterized in that, include: Image data of several AC16 myocardial cells in a culture dish are acquired to extract the spatial distribution features of the AC16 myocardial cells within the culture dish area. The spatial distribution features include location depth and intercellular spacing. Based on the spatial distribution characteristics and the corresponding deformation fitting values, the hypoxia injury characterization values of myocardial AC16 cells are determined to classify the degree of injury of the myocardial AC16 cells. Based on the aforementioned damage severity category, the cardiac AC16 cells in the culture dish were modulated and inhibited, including, Transforming growth factor (TGF) is stained and labeled to obtain its movement trajectory. Low-concentration regions in the culture dish are identified, and images of these regions are acquired. The contour features of AC16 myocardial cells in the low-concentration regions are analyzed based on continuous image frames to assess damage inhibition degree characterization parameters. Based on these damage inhibition degree characterization parameters, it is determined whether to continue injecting TGF. The injection of TGF is increased in the corresponding regions according to the damage inhibition degree characterization parameters. Alternatively, the transforming growth factor can be injected into the center of the culture dish, and the injection of the transforming growth factor can be carried out in densely distributed areas in the culture dish. The contour features include deformation recovery and color difference uniformity.
2. The method for inhibiting hypoxia injury in myocardial AC16 cells according to claim 1, characterized in that, The process of determining the hypoxia injury characterization value of AC16 myocardial cells based on the spatial distribution characteristics and the corresponding deformation fitting value includes... The sum of the ratio of location depth to location depth threshold and the ratio of intercellular distance threshold to intercellular distance is used as the first feature of hypoxia injury. The ratio of the deformation fitting value to the deformation fitting threshold is used as the second hypoxia injury feature. The weighted sum of the first hypoxia damage feature and the second hypoxia damage feature is used as the hypoxia damage characterization value.
3. The method for inhibiting hypoxia injury of myocardial AC16 cells according to claim 1, characterized in that, The degree of damage to the aforementioned AC16 myocardial cells was categorized into several types, including: If the hypoxia injury characterization value is greater than or equal to the hypoxia injury characterization threshold, the damage level of the myocardial AC16 cells is classified as a high-damage category. If the hypoxia injury characterization value is less than the hypoxia injury characterization threshold, the damage level of the myocardial AC16 cells is classified as low damage level.
4. The method for inhibiting hypoxia injury of myocardial AC16 cells according to claim 1, characterized in that, Based on the aforementioned damage severity category, the cardiac AC16 cells in the culture dish were modulated and inhibited, including, If the myocardial AC16 cells are classified as high-damage cells, transforming growth factor (TGF) is stained and labeled to obtain the TGF's movement trajectory. Low-concentration regions in the culture dish are identified, and images of these low-concentration regions are acquired. The contour features of myocardial AC16 cells within these low-concentration regions are analyzed based on consecutive image frames to assess damage inhibition degree characterization parameters. Based on these damage inhibition degree characterization parameters, it is determined whether to continue injecting TGF. The injection of TGF is increased in the corresponding regions according to the damage inhibition degree characterization parameters. If the AC16 myocardial cells are classified as low-damage, transforming growth factor is injected into the center of the culture dish, and the injection of transforming growth factor is performed in densely distributed areas within the culture dish.
5. The method for inhibiting hypoxia injury of myocardial AC16 cells according to claim 1, characterized in that, The process of obtaining the migration trajectory of the transforming growth factor includes, Continuous imaging of the culture dish is acquired at predetermined time intervals, and the fluorescence images of the transforming growth factor are recorded; Based on image analysis software, the fluorescence signal of the transforming growth factor in the fluorescence image is identified and located; The movement trajectory of the transforming growth factor is established based on the position coordinates of the fluorescence signal corresponding to adjacent time intervals.
6. The method for inhibiting hypoxia injury of myocardial AC16 cells according to claim 5, characterized in that, The process of identifying the low-concentration region in the culture dish includes, If the number of aggregated movement trajectories in any region is greater than or equal to the aggregation number threshold, then the region is identified as a low-concentration region.
7. The method for inhibiting hypoxia injury in myocardial AC16 cells according to claim 1, characterized in that, The process of assessing the characterization parameters of damage inhibition includes The ratio of deformation recovery to deformation recovery threshold is used as the first damage suppression feature; The ratio of color difference uniformity to color difference uniformity threshold is used as the second damage suppression feature; The sum of the first damage suppression feature and the second damage suppression feature is used as the damage suppression degree characterization value.
8. The method for inhibiting hypoxia injury of myocardial AC16 cells according to claim 1, characterized in that, Determining whether to continue injecting the transforming growth factor based on the damage inhibition degree characterization parameters includes: If the damage inhibition degree characterization parameter is less than the damage inhibition characterization parameter threshold, then it is determined that the transformation growth factor should continue to be injected.
9. The method for inhibiting hypoxia injury of myocardial AC16 cells according to claim 1, characterized in that, Based on the damage inhibition degree characterization parameters, the corresponding regions are injected with the transforming growth factor, including, The increase in the amount of transforming growth factor injected is negatively correlated with the damage inhibition degree characterization parameter.
10. The method for inhibiting hypoxia injury in myocardial AC16 cells according to claim 1, characterized in that, The process of identifying densely distributed regions in the culture dish includes, If the number of AC16 myocardial cells in any region is greater than or equal to the number threshold, then the region is identified as the densely distributed region.
Citation Information
Patent Citations
Method for repairing oxidative damage of human myocardial cells in vitro
CN116555173A
